CD16+ monocytes in predicting response to intranasal immunotherapy in patients with cerebrovascular pathology

  • E. Ya. Shevela Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
  • A. A. Ostanin Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
  • M. A. Tikhonova Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
  • M. N. Davydova Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
  • I. V. Meledina Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
  • E. R. Chernykh Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
DOI: https://doi.org/10.25557/2310-0435.2022.03.145-146
Keywords: Neuroimmunopathology

Abstract

Conference abstract

Published
2022-10-15
How to Cite
Shevela, E. Y., Ostanin, A. A., Tikhonova, M. A., Davydova, M. N., Meledina, I. V., & Chernykh, E. R. (2022). CD16+ monocytes in predicting response to intranasal immunotherapy in patients with cerebrovascular pathology. Patogenez (Pathogenesis), 20(3), 145-146. https://doi.org/10.25557/2310-0435.2022.03.145-146
Issue
Vol. 20 No. 3 (2022): Pathogenesis
Section
Brief reports